Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications
Ovarian cancer, one of the most common gynecological malignancies, ranks as the fifth leading cause of cancer death in women. To investigate the mechanism by which isoliquiritigenin (ISL) regulates the JAK/STAT signaling pathway in ovarian cancer intervention, this review integrates cellular, animal...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2026-06-01
|
| סדרה: | Frontiers in Pharmacology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1828829/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
